On October 25, 2018 Gilead Sciences, Inc. (Nasdaq: GILD) reported that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the fourth quarter of 2018 (Press release, Gilead Sciences, OCT 25, 2018, View Source;p=irol-newsArticle&ID=2373558 [SID1234530156]). The dividend is payable on December 28, 2018, to stockholders of record at the close of business on December 14, 2018. Future dividends will be subject to Board approval.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!